Assembly Biosciences (ASMB) Retained Earnings (2010 - 2026)

Assembly Biosciences' Retained Earnings history runs 17 years deep, the most recent figure standing at -$841.1 million for Q1 2026.

• In Q1 2026, Retained Earnings fell 332360.87% year-over-year to -$841.1 million; the TTM figure through Mar 2026 stood at -$841.1 million (down 332360.87% YoY), while the FY2025 annual figure was -$41000.0, up 100.0% from the prior year.
• Retained Earnings for Q1 2026 stood at -$841.1 million, down from -$41000.0 in the prior quarter.
• The five-year high for Retained Earnings was -$41000.0 in Q4 2025, with the low at -$844.9 million in Q2 2025.
• The 5-year median for Retained Earnings is -$513000.0 (2023), against an average of -$317.0 million.
• The sharpest annual moves came in 2024 and 2025: Retained Earnings slumped 1019560.49% in 2024, then surged 100.0% in 2025.
• Assembly Biosciences' Retained Earnings stood at -$724.5 million in 2022, then surged by 99.99% to -$81000.0 in 2023, then plunged by 1019560.49% to -$825.9 million in 2024, then soared by 100.0% to -$41000.0 in 2025, then tumbled by 2051426.83% to -$841.1 million in 2026.
• Business Quant data shows ASMB's Retained Earnings at -$841.1 million in Q1 2026, -$41000.0 in Q4 2025, and -$90000.0 in Q3 2025.